Patents by Inventor Victor M. Young

Victor M. Young has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Formulations and Dosage Forms of Oxidized Phospholipids
    Publication number: 20190008880
    Abstract: The current disclosure provides pharmaceutical compositions containing an oxidized phospholipid, such as 1-hexadecyl-2-(4?-carboxybutyl)-glycero-3-phosphocholine (VB-201) and a thermosoftening carrier, e.g., a poloxamer. The pharmaceutical competitions may further comprise an anti-adherent agent, such as talc and/or a thixotropic agent. The current disclosure further provides processes for preparing the pharmaceutical compositions. The disclosure further provides capsules containing the pharmaceutical compositions. Uses of such pharmaceutical compositions and capsules in treating inflammatory disorders are also disclosed.
    Type: Application
    Filed: June 8, 2018
    Publication date: January 10, 2019
    Inventors: Naamit SHER, Victor M. YOUNG, Alyn MCNAUGHTON, Massoud BAKHSHAEE, Ian Robert WILDING
  • Formulations and Dosage Forms of Oxidized Phospholipids
    Publication number: 20160220590
    Abstract: The current disclosure provides pharmaceutical compositions containing an oxidized phospholipid, such as 1-hexadecyl-2-(4?-carboxybutyl)-glycero-3-phosphocholine (VB-201) and a thermosoftening carrier, e.g., a poloxamer. The pharmaceutical compositions may further comprise an anti-adherent agent, such as talc and/or a thixotropic agent. The current disclosure further provides processes for preparing the pharmaceutical compositions. The disclosure further provides capsules containing the pharmaceutical compositions. Uses of such pharmaceutical compositions and capsules in treating inflammatory disorders are also disclosed.
    Type: Application
    Filed: February 8, 2016
    Publication date: August 4, 2016
    Inventors: Naamit SHER, Victor M. YOUNG, Alyn MCNAUGHTON, Massoud BAKHSHAEE, Ian Robert WILDING
  • Formulations and dosage forms of oxidized phospholipids
    Patent number: 9254297
    Abstract: The current disclosure provides pharmaceutical compositions containing an oxidized phospholipid, such as 1-hexadecyl-2-(4?-carboxybutyl)-glycero-3-phosphocholine (VB-201) and a thermosoftening carrier, e.g., a poloxamer. The pharmaceutical compositions may further comprise an anti-adherent agent, such as talc and/or a thixotropic agent. The current disclosure further provides processes for preparing the pharmaceutical compositions. The disclosure further provides capsules containing the pharmaceutical compositions. Uses of such pharmaceutical compositions and capsules in treating inflammatory disorders are also disclosed.
    Type: Grant
    Filed: March 11, 2013
    Date of Patent: February 9, 2016
    Assignee: Vascular Biogenics Ltd.
    Inventors: Naamit Sher, Victor M. Young, Alyn McNaughton, Massoud Bakhshaee, Ian Robert Wilding